Hypofractionated radiotherapy for stage I lung carcinomas: moderate hypofractionation optimizes outcome

I. Menoux (Strasbourg, France), D. Antoni (Strasbourg, France), P. Truntzer (Strasbourg, France), A. Keller (Strasbourg, France), G. Massard (Strasbourg, France), G. NoëL (Strasbourg, France)

Source: International Congress 2018 – Lung cancer: personalised medicine
Session: Lung cancer: personalised medicine
Session type: Poster Discussion
Number: 2212
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Menoux (Strasbourg, France), D. Antoni (Strasbourg, France), P. Truntzer (Strasbourg, France), A. Keller (Strasbourg, France), G. Massard (Strasbourg, France), G. NoëL (Strasbourg, France). Hypofractionated radiotherapy for stage I lung carcinomas: moderate hypofractionation optimizes outcome. 2212

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: